Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes
Pujol Autonell, Irma
Serracant Prat, Arnau
Cano Sarabia, Antonia María
Ampudia, Rosa Maria
Rodríguez Fernández, Silvia
Sánchez (Sànchez Pla), Álex
Vives Pi, Marta
MetadataShow full item record
Introduction: The development of new therapies to induce self-tolerance has been an important medical health challenge in type 1 diabetes. An ideal immunotherapy should inhibit the autoimmune attack, avoid systemic side effects and allow a-cell regeneration. Based on the immunomodulatory effects of
apoptosis, we hypothesized that apoptotic mimicry can help to restore tolerance lost in autoimmune diabetes. Objective: To generate a synthetic antigen-specific immunotherapy based on apoptosis features to specifically reestablish tolerance to a-cells in type 1 diabetes. Methods: A central event on the surface of apoptotic cells is the exposure of phosphatidylserine, which provides the main signal for efferocytosis. Therefore, phosphatidylserine-liposomes loaded with insulin peptides were generated to simulate apoptotic cells recognition by antigen presenting cells. The effect of antigen-specific phosphatidylserine-liposomes in the reestablishment of peripheral tolerance was assessed in NOD mice, the spontaneous model of autoimmune diabetes. MHC class II-peptide tetramers were used to analyze the T cell specific response after treatment with phosphatidylserine-liposomes loaded with peptides. Results: We have shown that phosphatidylserine-liposomes loaded with insulin peptides induce tolerogenic dendritic cells and impair autoreactive T cell proliferation. When administered to NOD mice, liposome signal was detected in the pancreas and draining lymph nodes. This immunotherapy arrests the autoimmune aggression, reduces the severity of insulitis and prevents type 1 diabetes by apoptotic mimicry. MHC class II tetramer analysis showed that peptide-loaded phosphatidylserine-liposomes expand antigen-specific CD4+ T cells in vivo. The administration of phosphatidylserine-free liposomes emphasizes the importance of phosphatidylserine in the modulation of antigen-specific CD4+ T cell expansion. Conclusions: We conclude that this innovative immunotherapy based on the use of liposomes constitutes a promising strategy for autoimmune diseases.
Is part ofPLoS One, 2015, vol. 10, núm.6, e0127057
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by, (c) Pujol Autonell, Irma et al., 2015
Showing items related by title, author, creator and subject.
Phosphatidylserine-liposomes Promote Tolerogenic Features on Dendritic cells in human Type 1 Diabetes by apoptotic Mimicry Rodríguez Fernández, Silvia; Pujol Autonell, Irma; Briansó Castilla, Ferran; Perna Barrull, David; Cano Sarabia, Antonia María; García Jimeno, Sonia; Villalba, Adrian; Sánchez (Sànchez Pla), Álex; Aguilera, Eva; Vázquez San Miguel, Federico; Verdaguer Autonell, Joan; Maspoch, Daniel; Vives Pi, Marta (Frontiers Media, 2018)Type 1 diabetes (T1D) is a metabolic disease caused by the autoimmune destruction of insulin-producing β-cells. With its incidence increasing worldwide, to find a safe approach to permanently cease autoimmunity and allow ...
Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity Pujol-Autonell, Irma; Ampudia, Rosa Maria; Planas, Raquel; Marin-Gallen, Silvia; Carrascal, Jorge; Sanchez, Alex; Marin, Ana; Puig-Domingo, Manuel; Pujol-Borrell, Ricardo; Verdaguer Autonell, Joan; Vives Pi, Marta (Public Library of Science, 2013)Introduction: Efferocytosis is a crucial process by which apoptotic cells are cleared by phagocytes, maintaining immune tolerance to self in the absence of inflammation. Peripheral tolerance, lost in autoimmune processes, ...
de Hollanda, Ana; Lecube Torelló, Albert; Rubio, Miguel Ángel; Sánchez Peña, Enric; Vilarrasa, Núria; Gregorio Oliva, José; Fernández-Soto, María Luisa; Salas-Salvadó, Jordi; Ballesteros-Pomar, María D.; Ciudin, Andreea; Torres, Ferran; Vidal, Concepción; Morales, María José; Valdés, Sergio; Pellitero, Silvia; Miñambres, Inka; Masmiquel, Lluís; Goday, Albert; Suarez, Lorena; Flores, Liliam; Bueno Díez, Marta; Caixàs, Assumpta; Bretón, Irene; Cámara, Rosa; Olbeyra, Romina; Penso, Rona; de la Cruz, María José; Simó-Servat, Andreu; Pereyra-García, Francisca María; López-Mezquita, Elena Teresa; Gils, Anna; Fidilio, Enzamaria; Bandrés, Orosia; Martínez, Ángel; Abuín, Jose; Marques-Pamies, Montserrat; Tuneu, Laura; Arteaga, Magdalena; Castañer, Olga; Goñi, Fernando; Arrizabalaga, Cristina; Botana, Manuel Antonio; Calañas, Alfonso (MDPI, 2020)Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after ...